• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Fentadol 12, 25, 50, 75, 100
    / Perrigo


    Active Ingredient
    Fentanyl 12.5, 25, 50, 75, 100 mcg/hr

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Transdermal Patch

    5 X 12.5 µg/hr (2.1 mg/patch)

    not in the basket chart 59911

    Transdermal Patch

    5 X 25 µg/hr (4.2 mg/patch)

    not in the basket chart 59912

    Transdermal Patch

    5 X 50 µg/hr (8.4 mg/patch)

    not in the basket chart 59913

    Transdermal Patch

    5 X 75 µg/hr (12.6 mg/patch)

    not in the basket chart 59914

    Transdermal Patch

    5 X 100 µg/hr (16.8 mg/patch)

    not in the basket chart 59915

    Related information


    Dosage

    Each patch is intended for 3 days of treatment (72 hours) only. The patch should be Replaced every 72 hours, unless the doctor has instructed otherwise. Due to slow absorption of the medicine to the skin, the effect of the preparation may not be apparent immediately after applying the first patch. Sometimes, the maximal effect is only apparent 24 hours after applying the first patch. Therefore, additional painkillers on the first day of treatment may be needed.
    See prescribing information for full details.


    Indications

    Management of chronic pain and intractable pain requiring opioid analgesia. Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.


    Contra-Indications

    Hypersensitivity to active substance or any of the excipients.  Patients who did not use an opioid analgesic in the past. Short period pain (e.g., after surgery). Patients with not chronic/persistent pain. Mild or moderate pain relief. Patients with severe breathing problems. Patients with severe impairment of the central nervous system function (e.g., brain damage). During treatment with monoamine oxidase (MAO) inhibitors, or within a minimum of 2 weeks of discontinuing those drugs. Lactation. Children under 2 years of age.


    Manufacturer
    Hexal AG
    CLOSE